EPERZANEL Trademark

Trademark Overview


On Thursday, November 29, 2012, a trademark application was filed for EPERZANEL with the United States Patent and Trademark Office. The USPTO has given the EPERZANEL trademark a serial number of 85790433. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Glaxo Group Limited. The EPERZANEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
eperzanel

General Information


Serial Number85790433
Word MarkEPERZANEL
Filing DateThursday, November 29, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, January 13, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 11, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 16, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Friday, December 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 3, 2012NEW APPLICATION ENTERED IN TRAM